MCMINN RACHEL enters NEUROGENE INC. with 1.25M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives

MCMINN RACHEL

Filed: 12/26/2023ACC: 0000950170-23-073110

InsiderMCMINN RACHELCIK 1606302

→

IssuerNEUROGENE INC.CIK 1404644

DirectorOfficer· Chief Executive Officer

Since Feb 2026

1.25M

Baseline shares

100% direct

1.25M

Direct ownership

1 position

64.20K

Derivative underlying

5 instruments

Security positions

All direct

Non-Derivative Holdings1

Common Stock

Direct

Shares owned1.25M

Total

1.25M direct1.25M

Security Title	Shares Owned	Ownership Type
Common Stock	1.25M	Direct
Total	1.25M	1.25M direct

Derivative Holdings5

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

5.37K

Shares owned

N/A

Exercise price

6.40

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

37.80K

Shares owned

N/A

Exercise price

20.22

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

1.72K

Shares owned

N/A

Exercise price

6.40

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

18.56K

Shares owned

N/A

Exercise price

11.79

Expiration

—

Exercise window

—

Stock Option (Right to Buy)

Direct

Underlying security

Common Stock

Underlying shares

756.00

Shares owned

N/A

Exercise price

25.32

Expiration

—

Exercise window

—

Total

Underlying

64.20K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option (Right to Buy) Direct	Common Stock	6.40	—	—	5.37K	N/A
Stock Option (Right to Buy) Direct	Common Stock	20.22	—	—	37.80K	N/A
Stock Option (Right to Buy) Direct	Common Stock	6.40	—	—	1.72K	N/A
Stock Option (Right to Buy) Direct	Common Stock	11.79	—	—	18.56K	N/A
Stock Option (Right to Buy) Direct	Common Stock	25.32	—	—	756.00	N/A
Total					64.20K	0.00